These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 8875224)

  • 1. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.
    Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L
    Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of beta-hexosaminidase A alpha-chain mRNA in two different variants of GM2-gangliosidosis.
    Budde-Steffen C; Steffen M; Siegel DA; Suzuki K
    Neuropediatrics; 1988 May; 19(2):59-61. PubMed ID: 2967444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A glycine250--> aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family.
    Trop I; Kaplan F; Brown C; Mahuran D; Hechtman P
    Hum Mutat; 1992; 1(1):35-9. PubMed ID: 1301189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase.
    Tse R; Vavougios G; Hou Y; Mahuran DJ
    Biochemistry; 1996 Jun; 35(23):7599-607. PubMed ID: 8652542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
    Arfi A; Bourgoin C; Basso L; Emiliani C; Tancini B; Chigorno V; Li YT; Orlacchio A; Poenaru L; Sonnino S; Caillaud C
    Neurobiol Dis; 2005 Nov; 20(2):583-93. PubMed ID: 15953731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advances in molecular genetics of GM2 gangliosidosis].
    Wakamatsu N
    Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chronic GM2 gangliosidosis variant with a HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts.
    Fernandes MJ; Hechtman P; Boulay B; Kaplan F
    Eur J Hum Genet; 1997; 5(3):129-36. PubMed ID: 9272736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tay-Sachs disease in Jacob sheep.
    Torres PA; Zeng BJ; Porter BF; Alroy J; Horak F; Horak J; Kolodny EH
    Mol Genet Metab; 2010 Dec; 101(4):357-63. PubMed ID: 20817517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual thermolability properties of beta-hexosaminidase: studies of enzyme from cultured cells and clinical implications.
    Prence EM; Zalewski I; Natowicz MR
    Am J Med Genet; 1996 Nov; 65(4):320-4. PubMed ID: 8923943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrovirus-mediated transfer and expression of beta-hexosaminidase alpha-chain cDNA in human fibroblasts from G(M2)-gangliosidosis B1 variant.
    Teixeira CA; Sena-Esteves M; Lopes L; Sá Miranda MC; Ribeiro MG
    Hum Gene Ther; 2001 Sep; 12(14):1771-83. PubMed ID: 11560770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration.
    Kyrkanides S; Miller JH; Brouxhon SM; Olschowka JA; Federoff HJ
    Brain Res Mol Brain Res; 2005 Feb; 133(2):286-98. PubMed ID: 15710246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
    Hechtman P; Boulay B; Bayleran J; Andermann E
    Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol.
    Bourgoin C; Emiliani C; Kremer EJ; Gelot A; Tancini B; Gravel RA; Drugan C; Orlacchio A; Poenaru L; Caillaud C
    Gene Ther; 2003 Oct; 10(21):1841-9. PubMed ID: 12960974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
    Myerowitz R
    Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrovirus-mediated enzymatic correction of Tay-Sachs defect in transduced and non-transduced cells.
    Guidotti J; Akli S; Castelnau-Ptakhine L; Kahn A; Poenaru L
    Hum Mol Genet; 1998 May; 7(5):831-8. PubMed ID: 9536087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation common in non-Jewish Tay-Sachs disease: frequency and RNA studies.
    Akerman BR; Zielenski J; Triggs-Raine BL; Prence EM; Natowicz MR; Lim-Steele JS; Kaback MM; Mules EH; Thomas GH; Clarke JT
    Hum Mutat; 1992; 1(4):303-9. PubMed ID: 1301938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. W474C amino acid substitution affects early processing of the alpha-subunit of beta-hexosaminidase A and is associated with subacute G(M2) gangliosidosis.
    Petroulakis E; Cao Z; Clarke JT; Mahuran DJ; Lee G; Triggs-Raine B
    Hum Mutat; 1998; 11(6):432-42. PubMed ID: 9603435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ assessment of beta-hexosaminidase activity.
    Lacorazza HD; Jendoubi M
    Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Tay-Sachs disease mutations from China.
    Akalin N; Shi HP; Vavougios G; Hechtman P; Lo W; Scriver CR; Mahuran D; Kaplan F
    Hum Mutat; 1992; 1(1):40-6. PubMed ID: 1301190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. II. Characterization and development of the regional- and cellular-specific abnormalities in the epididymis of mice with beta-hexosaminidase A deficiency.
    Adamali HI; Somani IH; Huang JQ; Gravel RA; Trasler JM; Hermo L
    J Androl; 1999; 20(6):803-24. PubMed ID: 10591619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.